Company Filing History:
3 out of 158 
2 out of 1,745 
Years Active: 2010-2013
Title: The Innovative Contributions of Jean-Daniel Abraham
Introduction
Jean-Daniel Abraham is a notable inventor based in Strasbourg, France. He has made significant contributions to the field of biotechnology, particularly in the development of therapeutic applications related to hepatitis C virus (HCV). With a total of 3 patents, his work has had a meaningful impact on medical research and treatment options.
Latest Patents
Abraham's latest patents focus on a composition comprising the polyprotein NS3/NS4 and the polypeptide NS5B of HCV. The invention relates to a peptidic compound that includes the polyprotein NS3/NS4 of the hepatitis C virus and the polypeptide NS5B. Additionally, the patents describe expression vectors, such as adenovirus and poxvirus, that contain nucleic sequences coding for these components. The inventive compound is designed for therapeutic applications, showcasing Abraham's commitment to advancing medical science.
Career Highlights
Throughout his career, Jean-Daniel Abraham has worked with prominent organizations, including Transgene S.A. and the Institut National de la Santé et de la Recherche Médicale. His experience in these institutions has allowed him to collaborate on groundbreaking research and development projects that address critical health issues.
Collaborations
Abraham has collaborated with esteemed colleagues, including Anne Fournillier and Maria Dimitrova-Tchomakov. These partnerships have further enriched his research endeavors and contributed to the success of his innovative projects.
Conclusion
Jean-Daniel Abraham's contributions to biotechnology and his innovative patents demonstrate his dedication to improving therapeutic options for hepatitis C. His work continues to inspire advancements in medical research and treatment methodologies.